Your browser doesn't support javascript.
loading
Lipidomics in drug discovery.
Vihervaara, Terhi; Suoniemi, Matti; Laaksonen, Reijo.
Afiliação
  • Vihervaara T; Zora Biosciences Oy, Biologinkuja 1, 02150 Espoo, Finland.
  • Suoniemi M; Zora Biosciences Oy, Biologinkuja 1, 02150 Espoo, Finland.
  • Laaksonen R; Zora Biosciences Oy, Biologinkuja 1, 02150 Espoo, Finland. Electronic address: reijo.laaksonen@zora.fi.
Drug Discov Today ; 19(2): 164-70, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24055840
Lipidomics is a rapidly growing technology that can be used in biomedical research to study disease mechanisms, identify novel disease biomarkers and drug efficacy biomarkers, and reveal off-target effects. Lipidomics can also be used to elucidate the mechanism of action of different drug compounds or as readouts in Mendelian randomization approaches. Furthermore, lipidomics can be utilized to identify deviations in metabolic and/or signaling pathways in different stages of disease. Therefore, as we discuss here, this emerging technology also has a substantial potential in various drug discovery programs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Descoberta de Drogas / Lipídeos Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Descoberta de Drogas / Lipídeos Idioma: En Ano de publicação: 2014 Tipo de documento: Article